Orum Therapeutics is a private biotech company developing a new class of therapeutic antibodies targeting cytosolic proteins for unmet medical needs in cancer and rare diseases. Orum leverages its unique cell-penetrating antibody platform, called Oromab™ to inhibit drug targets, previously undruggable by small molecules or current antibodytherapeutics. In contrast to other approaches, Orum’s antibody platform can intracellularly deliver an active antibody therapeutic or payload, is easily adaptable to target different cell types and intracellular proteins, and does not require chemical modification.

Biotechnology

Health Care

Therapeutics

Orum Therapeutics

SJ Lee

Susan B.

Peter U. Park

Olaf Christensen

Greg Dwyer

Leadership Team

Operations Team

Scientific Research Team

Teams at Orum Therapeutics

Leadership Team

Operations Team

Scientific Research Team